10/07/2026
We are proud to share that the Clear Cell Sarcoma Foundation’s research abstract has been accepted for a poster presentation at the 2026 Connective Tissue Oncology Society (CTOS) Annual Meeting!
CTOS brings together sarcoma researchers, physicians, patient advocates, and industry leaders from around the world to share new findings and advance care for people affected by sarcoma.
This presentation builds on CCSF’s ongoing collaboration with xCures, through which we have supported the collection and analysis of real-world data from people living with Clear Cell Sarcoma. By bringing patient experiences and data to the scientific community, we hope to deepen understanding of this ultra-rare cancer and help identify opportunities to improve research, treatment, and care.
At CTOS 2026, our team will present these findings while also connecting with researchers and advocates, learning about emerging developments in sarcoma, and exploring new opportunities for collaboration.
For a cancer as rare as CCS, progress depends on bringing patients, families, researchers, clinicians, and organizations together.
Thank you to our donors, patients, families, researchers, and supporters who make this work possible. Your support helps ensure that Clear Cell Sarcoma continues to have a voice in the broader sarcoma research community.
